Phase Ib study of inavolisib (INAVO) + weekly paclitaxel (wP) in patients (pts) with locally advanced/metastatic (LA/m) incurable solid tumors: Safety, pharmacokinetics (PK), and preliminary antitumor activity.

Authors: Seock-Ah Im, Guzman Alonso, Irene Moreno, Kristoffer Staal Rohrberg, Valentina Gambardella, Antoine Italiano, Samuel Lim, Sravanthi Cheeti, Peiqing Yu, Aneta Swat, Fabiola Amair-Pinedo, Dejan Juric

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.1062

Source: Full article

---

Abstract

1062